Safety, Pharmacokinetics, and Anti-inflammatory Effects of Intratracheal Recombinant Human Clara Cell Protein in Premature Infants with Respiratory Distress Syndrome
- 1 July 2005
- journal article
- clinical trial
- Published by Springer Nature in Pediatric Research
- Vol. 58 (1) , 15-21
Abstract
Pediatric Research publishes original papers, invited reviews, and commentaries on the etiologies of diseases of children and disorders of development, extending from molecular biology to epidemiology. Use of model organisms and in vitro techniques relevant to developmental biology and medicine are acceptable, as are translational human studies.Keywords
This publication has 27 references indexed in Scilit:
- Uteroglobin: a novel cytokine?Cellular and Molecular Life Sciences, 1999
- The human Clara cell protein: biochemical and biological characterisation of a natural immunosuppressorMultiple Sclerosis Journal, 1996
- Clara Cell Protein (CC-16) Induces a Phospholipase A2-Mediated Inhibition of Fibroblast Migration in VitroAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Tissue-specific expression of the gene coding for human Clara cell 10-kD protein, a phospholipase A2-inhibitory protein.Journal of Clinical Investigation, 1993
- Human urinary protein 1: Evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretionsClinica Chimica Acta, 1992
- Detection of a uteroglobin-like phospholipase A2 inhibitory protein in the circulation of rabbitsMolecular and Cellular Endocrinology, 1989
- Inhibition of phagocyte chemotaxis by uteroglobin, an inhibitor of blastocyst rejectionBiochemical Pharmacology, 1988
- Isolation and Amino Acid Composition of the Isotypes of a Rat Clara Cell Specific ProteinExperimental Lung Research, 1987
- Uteroglobin inhibits phospholipase A2 activityLife Sciences, 1986
- Mechanism of action of an antiprogesterone, RU486, in the rabbit endometriumEuropean Journal of Biochemistry, 1985